Skip to main content

Clinical rheumatology

This section is concerns all aspects of clinical rheumatology

Page 1 of 3

  1. Fictional portrayals of illness and medical management in film and television can reflect and perpetuate cultural stereotypes about illness. The aim of this study was to analyse fictional depictions of gout in...

    Authors: Christina Derksen, Rachel Murdoch, Keith J. Petrie and Nicola Dalbeth

    Citation: BMC Rheumatology 2021 5:4

    Content type: Research article

    Published on:

  2. The diagnosis of Behçet disease (BD) is challenging in many cases. The purpose of this study was to describe the clinical characteristics of patients at a referral BD clinic.

    Authors: Mina Kiafar, Seyedeh Tahereh Faezi, Amir Kasaeian, Azarakhsh Baghdadi, Sahar Kakaei, Seyed Ali Mousavi, Mohammad Nejadhosseinian, Farhad Shahram, Seyedeh Zahra Ghodsi, Hormoz Shams and Fereydoun Davatchi

    Citation: BMC Rheumatology 2021 5:2

    Content type: Research article

    Published on:

  3. Rheumatoid arthritis (RA) is characterized by systemic inflammation and bone and muscle loss. Recent research showed that obesity facilitates inflammation, but it is unknown if obesity also increases the risk ...

    Authors: Andreas Friedberger, Camille Figueiredo, Tobias Bäuerle, Georg Schett and Klaus Engelke

    Citation: BMC Rheumatology 2020 4:72

    Content type: Research article

    Published on:

  4. Pain is the clinical hallmark of patients in patients with autoinflammatory diseases (AID) caused by variants of the NLRP3-, MEFV- or TNFRSF1A gene. However, no systematical analysis of the clinical and psycholog...

    Authors: Elisabeth Mulazzani, Nicole Zolyniak, Elisabeth Noe, Matthias Mulazzani, Shahnaz Christina Azad, Tania Kümpfel and Eduard Kraft

    Citation: BMC Rheumatology 2020 4:71

    Content type: Research article

    Published on:

  5. Antineutrophil cytoplasmic antibodies (ANCA) and Anti-glomerular basement membrane (GBM) antibodies often induce rapidly progressive glomerulonephritis (RPGN). Some reports have demonstrated RPGN with the sequ...

    Authors: Mikiya Kato, Risa Wakiya, Tomohiro Kameda, Kousuke Inoue, Tadashi Sofue, Yusuke Ushio, Koichi Sugihara, Shusaku Nakashima, Hiromi Shimada, Mai Mahmoud Fahmy Mansour, Norimitsu Kadowaki and Hiroaki Dobashi

    Citation: BMC Rheumatology 2020 4:68

    Content type: Case report

    Published on:

  6. Takayasu’s arteritis (TA) is a granulomatous, large vessel vasculitis with a preponderance for young women. The inflammation results in disruption of the arterial endothelium causing stenosis, endoluminal thro...

    Authors: Shania Niromi Gunasekera, Chirath Madurapperuma, Nilusha Weerasooriya, Harindra Karunathilake and Ananda Jayanaga

    Citation: BMC Rheumatology 2020 4:66

    Content type: Case report

    Published on:

  7. Patients with rheumatoid arthritis (RA) have high mortality risk and are frequently treated in intensive care units (ICUs).

    Authors: Toshifumi Fujiwara, Kentaro Tokuda, Kenta Momii, Kyohei Shiomoto, Hidetoshi Tsushima, Yukio Akasaki, Satoshi Ikemura, Jun-ichi Fukushi, Jun Maki, Noriyuki Kaku, Tomohiko Akahoshi, Tomoaki Taguchi and Yasuharu Nakashima

    Citation: BMC Rheumatology 2020 4:64

    Content type: Research article

    Published on:

  8. Vascular cell adhesion molecule-1 (VCAM-1) is involved in the progression of glomerular and tubulointerstitial injury in lupus nephritis (LN) and can be easily assessed in urine. The aim of this study was to a...

    Authors: Andrese Aline Gasparin, Nicole Pamplona Bueno de Andrade, Vanessa Hax, Penélope Esther Palominos, Marina Siebert, Romulo Marx, Pedro Guilherme Schaefer, Francisco Veríssimo Veronese and Odirlei André Monticielo

    Citation: BMC Rheumatology 2020 4:67

    Content type: Research article

    Published on:

  10. The mixed cryoglobulinemia (MC) syndrome is a systemic inflammatory syndrome that causes small-to-medium vessel vasculitis due to cryoglobulin-containing immune complexes most commonly caused by chronic hepati...

    Authors: Nasam Alfraji, Vandan D. Upadhyaya, Christopher Bekampis and Halyna Kuzyshyn

    Citation: BMC Rheumatology 2020 4:58

    Content type: Case report

    Published on:

  11. The objectives of this study were to describe the profile of ankylosing spondylitis (AS) patients treated with either infliximab (IFX) or subcutaneous golimumab (GLM) treatment in Canadian routine care setting...

    Authors: Proton Rahman, Michael Starr, Derek Haaland, Louis Bessette, Michelle Teo, Emmanouil Rampakakis, Allen J. Lehman and Francois Nantel

    Citation: BMC Rheumatology 2020 4:56

    Content type: Research article

    Published on:

  12. Psoriasis is a chronic inflammatory disease of the skin affecting 2–3% of UK population. 30% of people affected by psoriasis will develop a distinct form of arthritis within 10 years of the skin condition onse...

    Authors: Jesus Miguens Blanco, Federica Borghese, Neil McHugh, Peter Kelleher, Raj Sengupta, Julian R. Marchesi and Sonya Abraham

    Citation: BMC Rheumatology 2020 4:60

    Content type: Study protocol

    Published on:

  13. The B cell chemoattractant CXCL13 is a promising biomarker in rheumatoid arthritis (RA), with a plausible role in supporting diagnosis, monitoring disease activity and as a prognostic value. It is a key chemok...

    Authors: Katie Bechman, Anthony Dalrymple, Charles Southey-Bassols, Andrew P. Cope and James B. Galloway

    Citation: BMC Rheumatology 2020 4:70

    Content type: Research article

    Published on:

  14. Different proportions of musculoskeletal or autoimmune manifestations associated with COVID-19 have been reported in literature. We performed a systematic review and meta-analysis with the aim of assessing the...

    Authors: Jacopo Ciaffi, Riccardo Meliconi, Piero Ruscitti, Onorina Berardicurti, Roberto Giacomelli and Francesco Ursini

    Citation: BMC Rheumatology 2020 4:65

    Content type: Research article

    Published on:

  15. Many patients with rheumatoid arthritis (RA) do not attain remission/low disease activity, remaining in a moderate disease activity state (MDAS) with ongoing disability and impaired quality of life (QoL). If p...

    Authors: Ian C. Scott, Julie Mount, Jane Barry and Bruce Kirkham

    Citation: BMC Rheumatology 2020 4:63

    Content type: Research article

    Published on:

  16. Musculoskeletal ultrasound (MSUS) and the multi-biomarker disease activity (MBDA) score are outcome measures that may aid in the management of rheumatoid arthritis (RA) patients. This study evaluated tofacitin...

    Authors: Amir A. Razmjou, Jenny Brook, David Elashoff, Gurjit Kaeley, Soo Choi, Tanaz Kermani and Veena K. Ranganath

    Citation: BMC Rheumatology 2020 4:55

    Content type: Research article

    Published on:

  18. Blood accessible biomarkers to assess disease activity and their response to therapies in Juvenile Dermatomyositis (JDM) are urgently needed. This pilot study aims to identify serum protein biomarkers associat...

    Authors: Shefa M. Tawalbeh, Wilfredo Marin, Gabrielle A. Morgan, Utkarsh J. Dang, Yetrib Hathout and Lauren M. Pachman

    Citation: BMC Rheumatology 2020 4:52

    Content type: Research article

    Published on:

  19. Long-term clinical registries are essential tools to evaluate new therapies in a patient population that differs from those in randomized clinical trials. The objectives are to describe the profile of rheumato...

    Authors: Proton Rahman, Philip Baer, Ed Keystone, Denis Choquette, Carter Thorne, Boulos Haraoui, Andrew Chow, Rafat Faraawi, Wojciech Olszynski, John Kelsall, Emmanouil Rampakakis, Allen J. Lehman and Francois Nantel

    Citation: BMC Rheumatology 2020 4:46

    Content type: Research article

    Published on:

  20. Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from...

    Authors: Naohiro Uchio, Atsushi Unuma, Toshiyuki Kakumoto, Masao Osaki, Yoshitaka Zenke, Kenichi Sakuta, Akatsuki Kubota, Yoshikazu Uesaka, Tatsushi Toda and Jun Shimizu

    Citation: BMC Rheumatology 2020 4:48

    Content type: Case report

    Published on:

  21. To determine whether initiation of a tumor necrosis factor inhibitor (TNFi) or methotrexate improves hemoglobin A1c in patients with psoriatic arthritis (PsA), rheumatoid arthritis (RA), or ankylosing spondyli...

    Authors: Santhi Mantravadi, Michael George, Colleen Brensinger, Min Du, Joshua F. Baker and Alexis Ogdie

    Citation: BMC Rheumatology 2020 4:39

    Content type: Research article

    Published on:

  22. Proteasomes are found in both the cell nucleus and cytoplasm and play a major role in the ubiquitin-dependent and -independent non-lysosomal pathways of intracellular protein degradation. Proteasomes are also ...

    Authors: Hiroshi Maruyama, Kouichi Hirayama, Marina Yamashita, Kentaro Ohgi, Ryuji Tsujimoto, Mamiko Takayasu, Homare Shimohata and Masaki Kobayashi

    Citation: BMC Rheumatology 2020 4:36

    Content type: Research article

    Published on:

  23. Giant cell arteritis (GCA) is a common large vessel vasculitis of the elderly, often associated with sight loss. Glucocorticoids (GC remain the mainstay of treatment, although biologic treatments have been app...

    Authors: Alwin Sebastian, Kornelis S. M. van der Geest, Fiona Coath, Prisca Gondo, Abdul Kayani, Craig Mackerness, Bernard Hadebe, Sue Innes, Jo Jackson and Bhaskar Dasgupta

    Citation: BMC Rheumatology 2020 4:35

    Content type: Study protocol

    Published on:

  24. Retroperitoneal fibrosis (RPF) is characterized by the proliferation of fibrous tissue in the retroperitoneum. The majority of RPF cases are due to idiopathic or IgG4-related disease. Recent studies on IgG4-re...

    Authors: Veronika Boyeva, Hatim Alabsi, Michael A. Seidman, Ryan Paterson, Jason Kur, Luke Y. C. Chen, Silvia D. Chang and Mollie Carruthers

    Citation: BMC Rheumatology 2020 4:40

    Content type: Research article

    Published on:

  25. Patients treated for cancer with immune checkpoint inhibitors (ICI) may develop autoimmune adverse events, including ICI-induced inflammatory arthritis (IA). ICI-induced IA treatment requires balancing immune ...

    Authors: Laura C. Cappelli, Suzanne M. Grieb, Ami A. Shah, Clifton O. Bingham III and Ana-Maria Orbai

    Citation: BMC Rheumatology 2020 4:32

    Content type: Research article

    Published on:

  26. To gain insight in the use of current systemic sclerosis (SSc) care provided by health professionals from the patient perspective. We focused on referral reasons, treatment goals, the alignment with unmet care...

    Authors: Juliane K. Stöcker, Madelon C. Vonk, Frank H. J. van den Hoogen, Maria W. G. Nijhuis-van der Sanden, Julia Spierings, J. Bart Staal, Ton Satink and Cornelia H. M. van den Ende

    Citation: BMC Rheumatology 2020 4:43

    Content type: Research article

    Published on:

  27. Dose loading of biological disease modifying anti-rheumatic drugs (bDMARDs) in auto-immune rheumatic diseases (AIRDs) is performed to achieve steady state drug concentrations earlier after treatment start comp...

    Authors: Gerlienke E. Geurts-Voerman, Lise M. Verhoef, Bart J. F. van den Bemt and Alfons A. den Broeder

    Citation: BMC Rheumatology 2020 4:37

    Content type: Research article

    Published on:

  28. Previous studies have linked rheumatoid arthritis (RA) risk and disease activity with vitamin D-deficiency (low serum 25-hydroxyvitamin D (25OHD)), but a causal role for vitamin D in RA is still unclear, with ...

    Authors: Stephanie R. Harrison, Gurpreet Jutley, Danyang Li, Ilfita Sahbudin, Andrew Filer, Martin Hewison and Karim Raza

    Citation: BMC Rheumatology 2020 4:38

    Content type: Research article

    Published on:

  29. Line blot immunoassays (LIA) for myositis-specific (MSA) and myositis-associated (MAA) autoantibodies have become commercially available. In the largest study of this kind, we evaluated the clinical performanc...

    Authors: Fergus To, Clara Ventín-Rodríguez, Shuayb Elkhalifa, James B. Lilleker and Hector Chinoy

    Citation: BMC Rheumatology 2020 4:28

    Content type: Research article

    Published on:

  31. Inflammatory Arthritis is characterized by lifelong medical treatment and an unpredictable trajectory because of the fluctuating nature of the diseases. Proactive disease management is recommended, which inclu...

    Authors: Bianca Bech, Jens Jørgen Lykkegaard, Tine Lundbak, Heidi Morsø Schrøder, Line Mette Birkeland, Mette Lund Schlyter, Lotte Hanne Hansen, Lillian Dalsgaard and Bente Appel Esbensen

    Citation: BMC Rheumatology 2020 4:44

    Content type: Research article

    Published on:

  32. Immune-mediated necrotising myopathy (IMNM) is characterised by severe muscle weakness and necrosis with a paucity of inflammation on muscle biopsy. Around 60% of cases are associated with antibodies to the si...

    Authors: Rhys Thomas, Su-Ann Yeoh, Rupert Berkeley, Andrew Woods, Mike Stevens, Silvia Marino and Aleksandar Radunovic

    Citation: BMC Rheumatology 2020 4:29

    Content type: Case report

    Published on:

  33. It is plausible that optimal cardiovascular disease (CVD) risk management differs in patients with rheumatoid arthritis (RA) from low or middle income compared to high income populations. This study aimed at p...

    Authors: Ahmed Solomon, Anne E. Stanwix, Santos Castañeda, Javier Llorca, Carlos Gonzalez-Juanatey, Bridget Hodkinson, Benitha Romela, Mahmood M. T. M. Ally, Ajesh B. Maharaj, Elsa M. Van Duuren, Joyce J. Ziki, Mpoti Seboka, Makgotso Mohapi, Barend J. Jansen Van Rensburg, Gareth S. Tarr, Kavita Makan…

    Citation: BMC Rheumatology 2020 4:42

    Content type: Research article

    Published on:

  34. Disease-modifying antirheumatic drugs (DMARDs) have transformed the treatment of numerous autoimmune and inflammatory diseases but their perceived risk of harm may be a barrier to use.

    Authors: Hiba EL Masri, Samantha A. Hollingworth, Mieke van Driel, Helen Benham and Treasure M. McGuire

    Citation: BMC Rheumatology 2020 4:27

    Content type: Research article

    Published on:

  35. Our study aimed to compare efficacy and safety of Hetero’s adalimumab (Mabura®, Hetero Biopharma Limited) versus reference adalimumab (Humira®, Abbvie Inc.) in Indian patients with active rheumatoid arthritis ...

    Authors: Shubhadeep Sinha, Biswadip Ghosh, Syamasis Bandyopadhyay, Firdaus Fatima, Vamsi Krishna Bandi, Pankaj Thakur, Bala Reddy, Sreenivasa Chary, Leela Talluri, Ajay Gupta, Amit Ramchandra Kale, Anil Kumar Gupta, Ashok Kumar P, Diwakar Reddy, Younus Mohammed, Soma Shekar…

    Citation: BMC Rheumatology 2020 4:24

    Content type: Research article

    Published on:

  36. In this commentary, we discuss the potential of advanced imaging, particularly Dynamic Contrast Enhanced (DCE) magnetic resonance imaging (MRI) for the objective assessment of the inflammatory process in rheum...

    Authors: Ali Mobasheri, Mark Hinton, Faiq Shaikh and Olga Kubassova

    Citation: BMC Rheumatology 2020 4:33

    Content type: Commentary

    Published on:

  37. Severe spinal pain is an unusual presentation of gout. Due to its rarity and the difficulty of obtaining joint fluid or tissue for crystal analysis, dual energy computed tomography (DECT) may be a useful imagi...

    Authors: Jeremy X. Wang, Beverly Ng, Haesung Bak, David Spencer, Nicholas Manolios and Peter K. K. Wong

    Citation: BMC Rheumatology 2020 4:22

    Content type: Case report

    Published on:

  38. Various inflammatory conditions may present with musculoskeletal symptoms similar to those of polymyalgia rheumatica (PMR). We investigated findings on 18F-fluorodexoxyglucose (FDG)-positron emission tomography/c...

    Authors: Hideyuki Horikoshi, Takashi Nakanishi, Katsumi Tamura, Fumihiko Kimura and Kenji Itoh

    Citation: BMC Rheumatology 2020 4:21

    Content type: Research article

    Published on:

  39. Despite contemporary advances in understanding pathogenesis and effective management of gout, beliefs about the disease continue to be focused on gout as a self-inflicted illness. The illness label itself may ...

    Authors: Nicola Dalbeth, Meihana Douglas, Kate MacKrill, Leanne Te Karu, Maria Kleinstäuber and Keith J. Petrie

    Citation: BMC Rheumatology 2020 4:23

    Content type: Research article

    Published on:

  40. Conservative, first-line treatments (exercise, education and weight-loss if appropriate) for hip and knee joint osteoarthritis are underused despite the known benefits. Clinicians’ beliefs can affect the advic...

    Authors: Daniel W. O’Brien, Sandra Bassett, Valerie Wright-St Clair and Richard J. Siegert

    Citation: BMC Rheumatology 2020 4:15

    Content type: Research article

    Published on:

  41. Rheumatoid arthritis is the most common type of inflammatory arthritis affecting about 1% of the population. With the advent of disease-modifying anti-rheumatic drugs the disease can be well controlled in many...

    Authors: Nils Schubert, Tillmann Schill, Marlene Plüß and Peter Korsten

    Citation: BMC Rheumatology 2020 4:11

    Content type: Case report

    Published on:

  42. Despite high risk for cardiovascular disease (CVD) mortality, screening and treatment of hyperlipidemia in patients with rheumatoid arthritis (RA) is suboptimal. We asked primary care physicians (PCPs) and rhe...

    Authors: Iris Navarro-Millán, Anna Cornelius-Schecter, Ronan J. O’Beirne, Melanie S. Morris, Geyanne E. Lui, Susan M. Goodman, Andrea L. Cherrington, Liana Fraenkel, Jeffrey R. Curtis and Monika M. Safford

    Citation: BMC Rheumatology 2020 4:14

    Content type: Research article

    Published on:

  43. Symptoms and comorbidities of ankylosing spondylitis (AS) considerably reduce health-related quality of life (HRQoL) and ability to work. This real-world study assessed rates of tumour necrosis factor inhibito...

    Authors: A. Deodhar, V. Strand, P. G. Conaghan, E. Sullivan, S. Blackburn, H. Tian, K. Gandhi, S. M. Jugl and R. Alten

    Citation: BMC Rheumatology 2020 4:19

    Content type: Research article

    Published on:

  44. Strategic drug therapy for rheumatoid arthritis (RA) patients with prolonged remission is not well defined. According to recent guidelines, tapering biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) ...

    Authors: Chayma Ladhari, Pierre Le Blay, Thierry Vincent, Ahmed Larbi, Emma Rubenstein, Rosanna Ferreira Lopez, Christian Jorgensen and Yves-Marie Pers

    Citation: BMC Rheumatology 2020 4:5

    Content type: Research article

    Published on:

  45. Patients with rheumatoid arthritis (RA) have increased cardiovascular (CV) and mortality risk. Patients with RA are also frequently prescribed glucocorticoids (GCs) which have been associated with increased ri...

    Authors: Ruth E. Costello, Antonia Marsden, Mohammad Movahedi, Mark Lunt, Jenny H. Humphreys, Richard Emsley and William G. Dixon

    Citation: BMC Rheumatology 2020 4:4

    Content type: Research article

    Published on:

  46. Peripheral ulcerative keratitis (PUK) is a severe inflammatory ocular disease that can affect patients with a long history of rheumatoid arthritis (RA). The use of biotherapy has revolutionized the treatment o...

    Authors: Sara Benchérifa, Bouchra Amine, Imane El Binoune, Samira Rostom and Rachid Bahiri

    Citation: BMC Rheumatology 2020 4:6

    Content type: Case report

    Published on:

  47. Joint replacements continue to occur during a rheumatoid arthritis (RA) patient’s lifetime despite significant advances in available treatment options. The purpose of this study was to examine and quantify syn...

    Authors: Evan A. Choate, Gurjit S. Kaeley, Jenny Brook, Roy D. Altman, John D. FitzGerald, Astrid R. Floegel-Shetty, David A. Elashoff and Veena K. Ranganath

    Citation: BMC Rheumatology 2020 4:8

    Content type: Research article

    Published on:

  48. S100A4 is a member of calcium binding S100 protein family well known for its role in cancer progression and metastasis. Nevertheless, S100A4 also serves as a negative regulator of bone formation. Dickkopf-1 (D...

    Authors: Barbora Šumová, Lucie Andrés Cerezo, Hana Hulejová, Klára Prajzlerová, Michal Tomčík, Kristýna Bubová, Jan Štěpán, Mária Filková, Tereza Kropáčková, Mariam Grigorian, Karel Pavelka, Jiří Vencovský and Ladislav Šenolt

    Citation: BMC Rheumatology 2020 4:13

    Content type: Research article

    Published on:

  49. Relapsing polychondritis (RPC) is a rare progressive autoimmune disease characterized by inflammation in the cartilage of multiple organs. Tracheobronchial involvement appears in nearly half of RPC patients du...

    Authors: Tomonori Makiguchi, Akira Koarai, Chihiro Inoue, Yayoi Aoyama, Taizo Hirano, Takashi Ohe, Tomohiro Ichikawa, Yutaka Shishikura, Hanae Komuro, Yoko Tsukita, Naoki Tode, Tadahisa Numakura, Tsutomu Saito, Teruyuki Sato, Yoshiya Mitsuhashi, Tsutomu Tamada…

    Citation: BMC Rheumatology 2020 4:1

    Content type: Case report

    Published on:

  50. A definite diagnosis of gout requires demonstration of monosodium urate crystals in synovial fluid or in tophi, which in clinical practice today seldom is done. Dual energy CT (DECT) has repeatedly been shown ...

    Authors: Elin Svensson, Ylva Aurell, Lennart T. H. Jacobsson, Anton Landgren, Valgerdur Sigurdardottir and Mats Dehlin

    Citation: BMC Rheumatology 2020 4:7

    Content type: Research article

    Published on:

BMC Rheumatology

ISSN: 2520-1026

Contact us